Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-26

Clinical Trial Update: Orphenadrine and Methocarbamol for LBP [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating orphenadrine and methocarbamol for low back pain was completed and results were posted in June 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOCARBAMOL (Methocarbamol)
  • Orphenadrine (Orphenadrine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Low Back Pain | Phase 4 | Status: COMPLETED | Results posted: 2018-06-26